Compare PGR & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGR | SYK |
|---|---|---|
| Founded | 1937 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.4B | 141.2B |
| IPO Year | N/A | N/A |
| Metric | PGR | SYK |
|---|---|---|
| Price | $227.19 | $356.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 15 |
| Target Price | $267.40 | ★ $432.13 |
| AVG Volume (30 Days) | ★ 3.2M | 1.7M |
| Earning Date | 01-28-2026 | 01-27-2026 |
| Dividend Yield | ★ 6.11% | 0.99% |
| EPS Growth | ★ 32.41 | N/A |
| EPS | ★ 18.22 | 7.61 |
| Revenue | ★ $85,166,000,000.00 | $24,381,000,000.00 |
| Revenue This Year | $12.54 | $11.98 |
| Revenue Next Year | $7.67 | $8.60 |
| P/E Ratio | ★ $12.48 | $46.84 |
| Revenue Growth | ★ 18.35 | 10.95 |
| 52 Week Low | $199.90 | $329.16 |
| 52 Week High | $292.99 | $406.19 |
| Indicator | PGR | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 44.50 |
| Support Level | $218.83 | $349.55 |
| Resistance Level | $237.44 | $359.81 |
| Average True Range (ATR) | 4.38 | 6.22 |
| MACD | -0.29 | 0.12 |
| Stochastic Oscillator | 50.39 | 39.78 |
Progressive underwrites private and commercial auto insurance and specialty lines; it has almost 24 million personal auto policies in force and is one of the largest auto insurers in the United States. Progressive markets its policies through independent insurance agencies in the US and Canada and directly via the internet and telephone. Its premiums are split roughly equally between the agent and the direct channel. The company also offers commercial auto policies and entered homeowners insurance through an acquisition in 2015.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.